Candel Therapeutics (NASDAQ: CADL) insider plans 7,000-share 10b5-1 sale

Rhea-AI Filing Summary

CADL reporting person Seshu P. Tyagarajan filed to sell 7,000 shares of common stock through Morgan Stanley Smith Barney LLC, with the shares listed on NASDAQ. The shares relate to Restricted Stock Units granted on 01/07/2025 and are associated with Rule 10b5-1 sales dated 06/29/2026, with disclosed transaction values of $82,040.00 and $70,151.20.

Key Figures

Shares to be sold: 7,000 shares Reported transaction value: $82,040.00 Recent 10b5-1 sale value: $70,151.20 +2 more

5 metrics

Shares to be sold 7,000 shares Common stock reported for sale under Form 144

Reported transaction value $82,040.00 Value shown in securities information section for the 7,000-share block

Recent 10b5-1 sale value $70,151.20 Amount associated with 7,000-share 10b5-1 sales dated 06/29/2026

RSU grant date 01/07/2025 Grant date of Restricted Stock Units tied to the common shares

10b5-1 sale date 06/29/2026 Date of 10b5-1 sales referenced for the 7,000 shares

Key Terms

Form 144, Restricted Stock Units, 10b5-1 Sales

3 terms

Form 144 regulatory

"144: Securities Information Common | Morgan Stanley Smith Barney LLC"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Units financial

"Common | 01/07/2025 | Restricted Stock Units | Issuer"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Sales regulatory

"10b5-1 Sales for SESHU P TYAGARAJAN"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

FAQ

What does CADL's Form 144 filing disclose about Seshu P. Tyagarajan?

The Form 144 discloses that Seshu P. Tyagarajan plans to sell 7,000 shares of CADL common stock through Morgan Stanley Smith Barney LLC, with the shares linked to Restricted Stock Units granted on 01/07/2025 and sales associated with a 10b5-1 plan.

How many CADL shares are covered by the planned sale in this Form 144?

The planned sale covers 7,000 shares of CADL common stock. These shares are reported under Morgan Stanley Smith Barney LLC Executive Financial Services, with related 10b5-1 sales activity also showing 7,000 shares tied to the same reporting person and securities.

What transaction values are reported in CADL's Form 144 for the 7,000-share sale?

The filing reports transaction-related values of $82,040.00 and $70,151.20 associated with the 7,000 CADL common shares. These figures appear in the securities information and recent 10b5-1 sales sections linked to the same block of shares.

What type of equity award is involved in CADL's Form 144 filing?

The Form 144 connects the planned sale of 7,000 CADL common shares to Restricted Stock Units. These RSUs are shown as granted on 01/07/2025 by the issuer, and the related common shares are now being reported for potential sale.

Is a Rule 10b5-1 trading plan mentioned in CADL's Form 144?

Yes. The filing references 10b5-1 sales for Seshu P. Tyagarajan involving 7,000 CADL common shares. This indicates that the reported sale activity is associated with a pre-arranged Rule 10b5-1 trading plan for those shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/17/2026 - 04:37 PM Accepted by SEC EDGAR 08/17/2026 - 04:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7000	82040.00	76518565	08/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/07/2025	Restricted Stock Units	Issuer			7000	01/07/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for SESHU P TYAGARAJAN 117 Kendrick St, Suite 450 Needham MA 02494	Common	06/29/2026	7000	70151.20

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)